Culine S - Search Results

1

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.

Pfister C, Gravis G, Fléchon A, Soulié M, Guy L, Laguerre B, Mottet N, Joly F, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Among authors: culine s. Eur Urol. 2021 Feb;79(2):214-221. doi: 10.1016/j.eururo.2020.08.024. Epub 2020 Aug 28. Eur Urol. 2021. PMID: 32868138 Clinical Trial.

2

Penile cancer chemotherapy: twelve years' experience at Institut Gustave-Roussy.

Kattan J, Culine S, Droz JP, Fadel E, Court B, Perrin JL, Wibault P, Haie-Meder C. Kattan J, et al. Among authors: culine s. Urology. 1993 Nov;42(5):559-62. doi: 10.1016/0090-4295(93)90273-d. Urology. 1993. PMID: 7694417

3

Treatment of sarcomatoid renal cell carcinoma: is there a role for chemotherapy?

Culine S, Bekradda M, Terrier-Lacombe MJ, Droz JP. Culine S, et al. Eur Urol. 1995;27(2):138-41. doi: 10.1159/000475145. Eur Urol. 1995. PMID: 7744156 Clinical Trial.

4

Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis and biological disease only after orchiectomy.

Culine S, Theodore C, Terrier-Lacombe MJ, Droz JP. Culine S, et al. J Urol. 1996 Apr;155(4):1296-8. J Urol. 1996. PMID: 8632558 Clinical Trial.

5

High-dose chemotherapy in germ-cell tumors.

Droz JP, Culine S, Biron P, Kramar A. Droz JP, et al. Among authors: culine s. Ann Oncol. 1996 Dec;7(10):997-1003. doi: 10.1093/oxfordjournals.annonc.a010523. Ann Oncol. 1996. PMID: 9037356 Free article. Review.

6

Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.

Culine S, Theodore C, Court BH, Perrin JL, Droz JP. Culine S, et al. Br J Urol. 1997 Feb;79(2):258-62. doi: 10.1046/j.1464-410x.1997.26119.x. Br J Urol. 1997. PMID: 9052479

7

Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.

Culine S, Theodore C, Terrier-Lacombe MJ, Droz JP. Culine S, et al. J Urol. 1997 Mar;157(3):855-8; discussion 858-9. J Urol. 1997. PMID: 9072585

8

Phase II study of all-trans retinoic acid administered intermittently for hormone refractory prostate cancer.

Culine S, Kramar A, Droz JP, Théodore C. Culine S, et al. J Urol. 1999 Jan;161(1):173-5. J Urol. 1999. PMID: 10037392 Clinical Trial.

9

Population pharmacokinetics of topotecan: intraindividual variability in total drug.

Montazeri A, Boucaud M, Lokiec F, Pinguet F, Culine S, Déporte-Féty R, Albin N, Laguerre B, Goupil A, Bugat R, Canal P, Chatelut E. Montazeri A, et al. Among authors: culine s. Cancer Chemother Pharmacol. 2000;46(5):375-81. doi: 10.1007/s002800000161. Cancer Chemother Pharmacol. 2000. PMID: 11127941 Clinical Trial.

10

Intensive and timely chemotherapy, the key of success in testicular cancer.

Fléchon A, Culine S, Droz JP. Fléchon A, et al. Among authors: culine s. Crit Rev Oncol Hematol. 2001 Jan;37(1):35-46. doi: 10.1016/s1040-8428(00)00074-3. Crit Rev Oncol Hematol. 2001. PMID: 11164717 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters